1097 related articles for article (PubMed ID: 31861847)
1. The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.
Wo YJ; Gan ASP; Lim X; Tay ISY; Lim S; Lim JCT; Yeong JPS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861847
[TBL] [Abstract][Full Text] [Related]
2. ADP ribosyl-cyclases (CD38/CD157), social skills and friendship.
Chong A; Malavasi F; Israel S; Khor CC; Yap VB; Monakhov M; Chew SH; Lai PS; Ebstein RP
Psychoneuroendocrinology; 2017 Apr; 78():185-192. PubMed ID: 28212520
[TBL] [Abstract][Full Text] [Related]
3. CD38, CD157, and RAGE as Molecular Determinants for Social Behavior.
Higashida H; Hashii M; Tanaka Y; Matsukawa S; Higuchi Y; Gabata R; Tsubomoto M; Seishima N; Teramachi M; Kamijima T; Hattori T; Hori O; Tsuji C; Cherepanov SM; Shabalova AA; Gerasimenko M; Minami K; Yokoyama S; Munesue SI; Harashima A; Yamamoto Y; Salmina AB; Lopatina O
Cells; 2019 Dec; 9(1):. PubMed ID: 31881755
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator.
Higashida H; Liang M; Yoshihara T; Akther S; Fakhrul A; Stanislav C; Nam TS; Kim UH; Kasai S; Nishimura T; Al Mahmuda N; Yokoyama S; Ishihara K; Gerasimenko M; Salmina A; Zhong J; Tsuji T; Tsuji C; Lopatina O
BMC Neurosci; 2017 Mar; 18(1):35. PubMed ID: 28340569
[TBL] [Abstract][Full Text] [Related]
5. Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.
Thai TL; Arendshorst WJ
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F169-76. PubMed ID: 19403649
[TBL] [Abstract][Full Text] [Related]
6. Re: CD157 in ovarian carcinoma: How does it help us?
Ortolan E; Ferrero E; Funaro A
J Natl Cancer Inst; 2010 Nov; 102(22):1741; author reply 1741-2. PubMed ID: 21057115
[No Abstract] [Full Text] [Related]
7. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology.
Malavasi F; Deaglio S; Funaro A; Ferrero E; Horenstein AL; Ortolan E; Vaisitti T; Aydin S
Physiol Rev; 2008 Jul; 88(3):841-86. PubMed ID: 18626062
[TBL] [Abstract][Full Text] [Related]
8. CD38 and CD157 ectoenzymes mark cell subsets in the human corneal limbus.
Horenstein AL; Sizzano F; Lusso R; Besso FG; Ferrero E; Deaglio S; Corno F; Malavasi F
Mol Med; 2009; 15(3-4):76-84. PubMed ID: 19052657
[TBL] [Abstract][Full Text] [Related]
9. CD157: From immunoregulatory protein to potential therapeutic target.
Ortolan E; Augeri S; Fissolo G; Musso I; Funaro A
Immunol Lett; 2019 Jan; 205():59-64. PubMed ID: 29936181
[TBL] [Abstract][Full Text] [Related]
10. The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors.
Konen JM; Fradette JJ; Gibbons DL
Cells; 2019 Dec; 9(1):. PubMed ID: 31878283
[TBL] [Abstract][Full Text] [Related]
11. CD38 and CD157: a long journey from activation markers to multifunctional molecules.
Quarona V; Zaccarello G; Chillemi A; Brunetti E; Singh VK; Ferrero E; Funaro A; Horenstein AL; Malavasi F
Cytometry B Clin Cytom; 2013; 84(4):207-17. PubMed ID: 23576305
[TBL] [Abstract][Full Text] [Related]
12. Distinct physical condition and social behavior phenotypes of CD157 and CD38 knockout mice during aging.
Gerasimenko M; Lopatina O; Shabalova AA; Cherepanov SM; Salmina AB; Yokoyama S; Goto H; Okamoto H; Yamamoto Y; Ishihara K; Higashida H
PLoS One; 2020; 15(12):e0244022. PubMed ID: 33326496
[TBL] [Abstract][Full Text] [Related]
13. CD157: From Myeloid Cell Differentiation Marker to Therapeutic Target in Acute Myeloid Leukemia.
Yakymiv Y; Augeri S; Fissolo G; Peola S; Bracci C; Binaschi M; Bellarosa D; Pellacani A; Ferrero E; Ortolan E; Funaro A
Cells; 2019 Dec; 8(12):. PubMed ID: 31817547
[No Abstract] [Full Text] [Related]
14. Blending oxytocin and dopamine with everyday creativity.
Chong A; Tolomeo S; Xiong Y; Angeles D; Cheung M; Becker B; Lai PS; Lei Z; Malavasi F; Tang Q; Chew SH; Ebstein RP
Sci Rep; 2021 Aug; 11(1):16185. PubMed ID: 34376746
[TBL] [Abstract][Full Text] [Related]
15. Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
Mahaweni NM; Bos GMJ; Mitsiades CS; Tilanus MGJ; Wieten L
Cancer Immunol Immunother; 2018 Jun; 67(6):861-872. PubMed ID: 29500635
[TBL] [Abstract][Full Text] [Related]
16. Roles of CD38 in the Immune Response to Infection.
GlarÃa E; Valledor AF
Cells; 2020 Jan; 9(1):. PubMed ID: 31963337
[TBL] [Abstract][Full Text] [Related]
17. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
18. The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.
Lo Buono N; Parrotta R; Morone S; Bovino P; Nacci G; Ortolan E; Horenstein AL; Inzhutova A; Ferrero E; Funaro A
J Biol Chem; 2011 May; 286(21):18681-91. PubMed ID: 21478153
[TBL] [Abstract][Full Text] [Related]
19. Novel peptide inhibitor of ecto-ADP-ribosyl cyclase of bone marrow stromal cell antigen-1 (BST-1/CD157).
Sato A; Yamamoto S; Ishihara K; Hirano T; Jingami H
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):491-6. PubMed ID: 9895292
[TBL] [Abstract][Full Text] [Related]
20. CD38-NAD
Chatterjee S; Chakraborty P; Mehrotra S
Aging (Albany NY); 2019 Oct; 11(20):8743-8744. PubMed ID: 31645480
[No Abstract] [Full Text] [Related]
[Next] [New Search]
